According to the proceeding's 4th Case Management Order dated November 17th, the Court has signed and entered orders regarding the implementation of Long and Short Form Pleadings, as well as an implementation order regarding Plaintiffs and Defendants fact sheets. Other Orders entered by the Court in recent weeks include an Order Governing Electronically Stored Data and a Final Protective Order.
The 4th Case Management Order also indicates that the parties are in the process of meeting and conferring on a proposed deposition protocol, the scope of written discovery, the bellwether selection process, and a bellwether trial date.
"Our Firm is representing a number of Stryker hip lawsuit plaintiffs, and we are pleased to see that so much progress has been made in the New Jersey litigation. We will continue to monitor this proceeding for any developments that may affect our clients' cases," said Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to individuals who may have been harmed by Stryker's LFIT Anatomic CoCr V40 Femoral Heads.
Stryker LFIT V40 Femoral Head Recall
Court records indicate that approximately 150 hip replacement lawsuits have been filed in Bergen County Superior Court involving Stryker's LFIT V40 femoral head components. These devices are used with various Stryker modular hip stems, including:
- Accolade TMZF Femoral Stem
- Accolade II Femoral Stem
- Restoration Femoral Hip Stem
- Rejuvenate Monolithic Stem
- ABG II Monolithic Femoral Stem
- Hipstar Femoral Stem
- Citation TMZF HA Stem
- Meridian PA Femoral Stem
- Exeter V40 Femoral Stem
- Reliance PF Femoral Stem
In August 2016, Stryker announced that certain LFIT Anatomic CoCr V40 Femoral Heads manufactured prior to 2011 were being recalled due to an unusually high number of reports involving taper lock failure. Taper lock failure may result in loosening of the artificial joint and other debilitating complications, including:
- Loss of mobility
- Adverse local tissue reaction
- Joint instability
- Bone fractures around the components
- Leg length discrepancy
- Need for revision surgery
The U.S. Food & Drug Administration (FDA) designated Stryker's action a Class II recall, which indicates that the affected components could cause temporary or medically-reversible health consequences.
Compensation may be available to individuals who suffered serious and debilitating complications allegedly related to Stryker's LFIT Anatomic CoCr V40 Femoral Head components. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.